Ziehm, M;
Kaur, S;
Ivanov, DK;
Ballester, PJ;
Marcus, D;
Partridge, L;
Thornton, JM;
(2017)
Drug repurposing for aging research using model organisms.
Aging Cell
, 16
(5)
pp. 1006-1015.
10.1111/acel.12626.
Preview |
Text
Ziehm_et_al-2017-Aging_Cell.pdf - Published Version Download (649kB) | Preview |
Preview |
Text (Figure 1)
Ziehm_Drug_repurposing_aging_research_S1.pdf Download (37kB) | Preview |
Preview |
Text (Figure 2)
Ziehm_Drug_repurposing_aging_research_S2.pdf Download (369kB) | Preview |
Spreadsheet (Table 1)
Ziehm_Drug_repurposing_aging_research_S3.xls Download (996kB) |
|
Preview |
Text (Table 2)
Ziehm_Drug_repurposing_aging_research_S4.pdf Download (538kB) | Preview |
Spreadsheet (Table 3)
Ziehm_Drug_repurposing_aging_research_S5.xls Download (257kB) |
|
Spreadsheet (Table 4)
Ziehm_Drug_repurposing_aging_research_S6.xls Download (275kB) |
|
Text (Data file 1)
Ziehm_Drug_repurposing_aging_research_S9.txt Download (2kB) |
|
Preview |
Text (Data file 2)
Ziehm_Drug_repurposing_aging_research_S10.pdf Download (368kB) | Preview |
Abstract
Many increasingly prevalent diseases share a common risk factor: age. However, little is known about pharmaceutical interventions against aging, despite many genes and pathways shown to be important in the aging process and numerous studies demonstrating that genetic interventions can lead to a healthier aging phenotype. An important challenge is to assess the potential to repurpose existing drugs for initial testing on model organisms, where such experiments are possible. To this end, we present a new approach to rank drug-like compounds with known mammalian targets according to their likelihood to modulate aging in the invertebrates Caenorhabditis elegans and Drosophila. Our approach combines information on genetic effects on aging, orthology relationships and sequence conservation, 3D protein structures, drug binding and bioavailability. Overall, we rank 743 different drug-like compounds for their likelihood to modulate aging. We provide various lines of evidence for the successful enrichment of our ranking for compounds modulating aging, despite sparse public data suitable for validation. The top ranked compounds are thus prime candidates for in vivo testing of their effects on lifespan in C. elegans or Drosophila. As such, these compounds are promising as research tools and ultimately a step towards identifying drugs for a healthier human aging.
Type: | Article |
---|---|
Title: | Drug repurposing for aging research using model organisms |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1111/acel.12626 |
Publisher version: | http://dx.doi.org/10.1111/acel.12626 |
Language: | English |
Additional information: | Copyright © 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. - Supplementary data file (Zip-Archive of all report cards) available on journal website. |
Keywords: | C. elegans, Drosophila, aging, computational predictions, drug repurposing, lifespan |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences > Genetics, Evolution and Environment |
URI: | https://discovery.ucl.ac.uk/id/eprint/1563699 |
Archive Staff Only
View Item |